{"data":{"ticker":"KROS","name":"Keros Therapeutics, Inc.","cik":"0001664710","quarterly":[{"frame":"CY2023Q3","end":"2023-09-30","revenue":8000,"netIncome":-39440000,"epsDiluted":-1.33,"fiscalPeriod":"Q3 FY 2023","fiscalYear":"FY 2023"},{"frame":"CY2023Q4","end":"2023-12-31","revenue":143000,"netIncome":-40243000,"epsDiluted":null,"derived":true,"fiscalPeriod":"Q4 FY 2023","fiscalYear":"FY 2023"},{"frame":"CY2024Q1","end":"2024-03-31","revenue":83000,"netIncome":-43114000,"epsDiluted":-1.21,"fiscalPeriod":"Q1 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2024Q2","end":"2024-06-30","revenue":37000,"netIncome":-45257000,"epsDiluted":-1.25,"fiscalPeriod":"Q2 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2024Q3","end":"2024-09-30","revenue":388000,"netIncome":-52956000,"epsDiluted":-1.41,"fiscalPeriod":"Q3 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2024Q4","end":"2024-12-31","revenue":3042000,"netIncome":-46026000,"epsDiluted":null,"derived":true,"fiscalPeriod":"Q4 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2025Q1","end":"2025-03-31","revenue":211246000,"netIncome":148451000,"epsDiluted":3.62,"fiscalPeriod":"Q1 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2025Q2","end":"2025-06-30","revenue":18168000,"netIncome":-30696000,"epsDiluted":-0.76,"fiscalPeriod":"Q2 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2025Q3","end":"2025-09-30","revenue":14262000,"netIncome":-7280000,"epsDiluted":-0.18,"fiscalPeriod":"Q3 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2025Q4","end":"2025-12-31","revenue":385000,"netIncome":-23461000,"epsDiluted":null,"derived":true,"fiscalPeriod":"Q4 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2026Q1","end":"2026-03-31","revenue":367000,"netIncome":-23708000,"epsDiluted":-1.21,"fiscalPeriod":"Q1 FY 2026","fiscalYear":"FY 2026"},{"frame":"CY2026Q2","end":"2026-06-30","revenue":0,"netIncome":-28710000,"epsDiluted":-1.45,"fiscalPeriod":"Q2 FY 2026","fiscalYear":"FY 2026"}],"annual":[{"frame":"CY2020","end":"2020-12-31","fiscalYear":"FY 2020","revenue":0,"netIncome":-45361000,"operatingCashFlow":-36894000,"capex":294000,"buybacks":null,"dividends":null},{"frame":"CY2021","end":"2021-12-31","fiscalYear":"FY 2021","revenue":20100000,"netIncome":-58744000,"operatingCashFlow":-62148000,"capex":1024000,"buybacks":null,"dividends":null},{"frame":"CY2022","end":"2022-12-31","fiscalYear":"FY 2022","revenue":0,"netIncome":-104679000,"operatingCashFlow":-70062000,"capex":1241000,"buybacks":null,"dividends":null},{"frame":"CY2023","end":"2023-12-31","fiscalYear":"FY 2023","revenue":151000,"netIncome":-152992000,"operatingCashFlow":-124508000,"capex":2464000,"buybacks":null,"dividends":null},{"frame":"CY2024","end":"2024-12-31","fiscalYear":"FY 2024","revenue":3550000,"netIncome":-187353000,"operatingCashFlow":-160869000,"capex":1931000,"buybacks":0,"dividends":null},{"frame":"CY2025","end":"2025-12-31","fiscalYear":"FY 2025","revenue":244061000,"netIncome":87014000,"operatingCashFlow":107505000,"capex":1551000,"buybacks":375000000,"dividends":null}],"latest":{"end":"2026-06-30","cash":257606000,"debt":null,"equity":262320000,"assets":287600000,"sharesOutstanding":19827188,"sharesDate":"2026-07-27","form":"10-Q"},"source":"SEC XBRL companyfacts, values as filed in USD","canonicalUrl":"https://xoomar.com/markets/stocks/kros"},"updatedAt":"2026-11-03T19:40:40.082Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/kros","meta":{"source":"SEC","sourceAttribution":"Financial statement data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}